Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
-
Provectus Biopharmaceuticals, Inc. Announces Closing of Public Offering
-
Provectus Biopharma (PVCT) Prices $6M Conv. Preferred Stock Offering
-
Provectus Biopharmaceuticals, Inc. Announces Pricing of Public Offering to Raise $6 Million
-
Provectus Biopharma (PVCT) to Offer Common Stocks and Warrants
-
Provectus Biopharmaceuticals, Inc. Announces Proposed Public Offering of Preferred Stock and Warrants
-
Provectus Biopharma (PVCT) Enters LOI with Boehringer Ingelheim to Bring PV-10 into China
-
Provectus Biopharmaceuticals Signs Letter of Intent with Boehringer Ingelheim (China) to Collaborate in Bringing PV-10 to Market in China
-
Provectus Biopharmaceuticals, Inc. Announces Closing of Public Offering
-
Provectus Biopharma (PVCT) Prices 17.5M Common, Warrants Offering at 75c/Unit
-
Provectus Biopharmaceuticals, Inc. Announces Pricing of Public Offering to Raise $13.1 Million
-
Provectus Biopharma (PVCT) to Offer Common Stock and Warrants
-
Provectus Biopharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants

